Heidi April, PHYSICIAN ASSISTANT
What this data tells you about April
Heidi April is a medical physician assistant in Richland, WA, with 8 years of NPI registration. Based on federal Medicare data, April performed 417 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, April received a total of $50 from 2 pharmaceutical and/or device companies across 2 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for April is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary — 2023
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
233 | $33 | $50 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
30 | $50 | $273 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $46 | $191 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
22 | $33 | $50 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
17 | $34 | $50 |
| Chlamydia pneumoniae nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of Chlamydia pneumoniae bacteria in a sample. |
14 | $32 | $50 |
| Mycoplasma pneumoniae nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of Mycoplasma pneumoniae bacteria. |
14 | $32 | $50 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
12 | $2 | $20 |
| Respiratory virus nucleic acid test, 3-5 targets A laboratory test that uses nucleic acid detection to identify multiple types or subtypes of respiratory viruses. The test analyzes 3 to 5 specific viral targets. |
12 | $128 | $225 |
| COVID-19 nucleic acid test, high throughput A laboratory test that detects the genetic material of the SARS-CoV-2 virus using an amplified probe technique. This method utilizes high-throughput technologies to process samples. |
12 | $74 | $185 |
| COVID-19 nucleic acid test, high throughput A laboratory test that detects the genetic material of the SARS-CoV-2 virus using amplified probe techniques. This method utilizes high-throughput technologies to process samples efficiently. |
12 | $24 | $45 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
11 | $34 | $50 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
April is a mixed practice specialist, with above-average Medicare volume (top 30% in WA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is April experienced with infectious disease dna/rna test?
Does April receive payments from pharmaceutical companies?
How do April's costs compare to other medical physician assistants in Richland?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology